Attached files
| file | filename |
|---|---|
| 8-K - MedPro Safety Products, Inc. | v176539_8k.htm |
This release includes forward-looking statements based upon current expectations of the
management of MedPro Safety Products,
Inc. that involve risks and uncertainties, such as
plans, objectives, expectations and intentions. Actual results and the timing of events
could differ materially from those anticipated in these forward- looking statements as a
result of a number
of factors, including our ability to identify and acquire medical safety
device safety technologies with product development potential; our ability to successfully
develop and bring products to market, including obtaining regulatory approvals; our ability
to successfully increase sales of our products; the ability of our products to compete in the
market for medical devices; our ability to obtain additional financing on satisfactory terms;
our ability to attract and retain qualified employees; and
governmental regulation
associated with the medical safety products industry. Words such as "anticipate,"
"estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will,"
"should," "could," and similar expressions
are used to identify forward-looking statements.
We refer you to the more detailed discussion of risks and uncertainties under "Risk
Factors" in our Annual Report on Form 10-K and our other reports on file with the
Securities and Exchange Commission.
Safe Harbor Statement
Cowen Healthcare Conference
Craig Turner, CEO MedPro Safety Products
Protecting Healthcare Professionals
OTCBB:MPSP
64% of nurses report being stuck by a needle while working
American Nurses Association, 2008 Workplace Safety and Needlestick Injuries Study
The Need for Better Safety Technology
Bloodborne Pathogen
Microorganisms present in
human blood that can cause
disease in humans
OSHA
Over 20
others
HIV
Hepatitis B
Hepatitis C
Risks of a Sharps Injury
3M
2M
1M
1 Million Reported Needlesticks Annually
3 Million Estimated Needlesticks Annually
International Sharps Injury Prevention Society, www.isips.org
Frequency of a Sharps Injury
Healthcare Worker
A healthcare worker exposed to a needlestick must be tested and
treated for possible disease for up to 1 year
Lack of Safety Results in:
Possible permanent harm
Loss in productivity
Concern for well being
“An overwhelming majority of nurses (87 percent) say safety concerns
influence their decisions about the type of nursing they do and their
continued practice in the field”
American Nurses Association, 2008 Workplace Safety and Needlestick Injuries Study
Healthcare Professionals at Risk
Healthcare Facility
A key element of risk management for facilities
is preventing needlestick incidents from occurring
Cost for needlestick exposure averages $3,000
per incident. This cost is incurred regardless of
infection being present
Loss of productivity by employee
Employer liability
“Using safer devices can prevent up to 83% of needlesticks”
OSHA
Employers at Risk
Protecting the Healthcare Worker
Federal
Government
OSHA
Bloodborne
Pathogen
Standard
Federal
Needlestick
Safety &
Prevention
Act
3
2
1
Outlines overall process of adoption of safer devices
Requires evaluation of safer medical devices
Requires input from non managerial personnel
Goal: “Isolate or remove the bloodborne pathogen
hazard from the workplace”
OSHA
Federal Needlestick Safety and Prevention Act
Slide
Snap
Retractable
Current Market – Active Safety
Active Safety Devices are the current market norm
Requires activation by the user after the procedure
User is required to perform additional step(s) outside of routine
Many times the safety features are not activated and risk is not reduced
ACTIVE
SAFETY
Current Market - Active Safety
Evolution of Sharps Safety
Unprotected
Sharps
Disposal
Active
Technology
Passive
Technology
“Automatic”
Past
Passive Sharps Safety
A Passive Safety Feature is one that requires no activation
by the user
“Today, there are very few safety-engineered medical
devices that require no active step to make a device safer
during use, after use and prior to disposal.”
Centers for Disease Control
Infection Control Today, 2009
Passive Products:
Automatic
Reduce Risk – Eliminate Operator Error
Ease of Use
No Change in Technique
Reduction in Employer Liability
All Safety Guards are brought to the patient
Protecting the Healthcare Worker
Completely Passive Portfolio
Phlebotomy
Pharma
Clinical
Intravenous
MedPro Market Segments
Passive Tube Activated Holder
Phlebotomy
Pharma
Passive Prefilled Drug Delivery System
Automatic Safety Activation
Automatic Safety Activation
Infusion
Passive IV Winged
Collection Set
Passive
Catheter
Clinical
Passive Hypodermic Safety Syringe
Automatic Safety Activation
Company
Product Uncertainty
Overhead Costs – Product directly to Market
Strategic Disadvantage – Lacking relationships, network
Results
Typical Business Model
MedPro Business Model
Phlebotomy
Pharma
Clinical
Intravenous
Strategic Partners
In
Development
Typical Market Model
Company
MedPro Model
Guaranteed Minimum Contracts
Global Strategic Partners
Distributor Commitment
Financial Stability
Better Capital Planning
Strong Passive IP Portfolio
Model Comparison
A New Beginning in Passive Safety